NAFF Arabic Validation Study
Cross-cultural Adaptation and Validation of the Nottingham Assessment of Functional Footcare (NAFF) Questionnaire Among Arabic-speaking Adults With Diabetes in Tunisia
1 other identifier
observational
255
1 country
1
Brief Summary
This study aims to evaluate a new Arabic version of the NAFF questionnaire, which measures foot care behaviors in adults with type 2 diabetes. Participants are adults with type 2 diabetes who will complete the questionnaire online. The study will assess how reliable and valid the Arabic version is, helping healthcare providers identify risky foot care behaviors and improve patient education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedFirst Submitted
Initial submission to the registry
August 29, 2025
CompletedFirst Posted
Study publicly available on registry
December 9, 2025
CompletedDecember 9, 2025
August 1, 2025
6 months
August 29, 2025
December 5, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Translation and adaptation
Translation, cultural adaptation, and assessment of content validity through expert panel evaluation using a 4-point relevance scale. Content validity index calculated by dividing items rated 3-4 by total items (n=29). Values ≥0.80 considered acceptable.
01/06/ 2021-31/07/ 2021 (2 months)
Descriptive data
Participants were asked to complete the NAFF-A questionnaire in the waiting room before clinical consultation. Demographic and clinical data were collected from medical records in collaboration with attending physicians, including gender, age, educational level, residence, diabetes duration, HbA1c levels, and history of ulceration or amputation.
01/08/2021 to 28/11/2021 (4 months)
Test-Retest Reliability of NAFF-A (Intraclass Correlation Coefficient)
Assessment of temporal stability of the NAFF-A using intraclass correlation coefficient (ICC) between test and retest administrations. Values ≥0.70 indicate good reliability, with higher values indicating better temporal stability.
Test-retest interval of 10-14 days between initial assessment and follow-up assessment.
Secondary Outcomes (4)
Internal consistency
At the end of data collection
Criterion Validity - Correlation with Educational Level
At the end of data collection
Criterion Validity - Correlation with HbA1c Levels
At the end of data collection
Criterion Validity - Correlation with Ulceration Risk Stratification
At the end of data collection
Eligibility Criteria
Patients with type 2 diabetes.
You may qualify if:
- Adults diagnosed with type 2 diabetes mellitus
- Age 26-65 years
- Ability to read and understand Arabic
- Receiving regular follow-up care at the endocrinology outpatient clinic
You may not qualify if:
- Cognitive impairments affecting comprehension or self-care activities
- Physical disabilities hindering self-care activities
- Presence of active foot ulcers at time of enrollment
- Bilateral lower-limb amputations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Farhat Hached University Hospital, Endocrinology Department
Sousse, Sousse Governorate, 4000, Tunisia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctorante, Investigateur Principal
Study Record Dates
First Submitted
August 29, 2025
First Posted
December 9, 2025
Study Start
June 1, 2021
Primary Completion
November 30, 2021
Study Completion
November 30, 2021
Last Updated
December 9, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly due to ethical constraints and participant privacy protections as per the Ethics Committee approval (CEFMS 81/2021) and Tunisian data protection regulations. Aggregate data and statistical results are available through the published manuscript. Researchers interested in collaboration may contact the principal investigator to discuss potential data sharing arrangements that comply with ethical and regulatory requirements.